Myocardial cell-to-cell communication via microRNAs

Lara Ottaviani¹, Marida Sansonetti¹, Paula A da Costa Martins^{1

2}

Affiliations

¹ Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
² Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, Porto, Portugal.

Review

Lara Ottaviani et al. Noncoding RNA Res. 2018.

. 2018 May 30;3(3):144-153.

doi: 10.1016/j.ncrna.2018.05.004. eCollection 2018 Sep.

Lara Ottaviani¹, Marida Sansonetti¹, Paula A da Costa Martins^{1

2}

¹ Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
² Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, Porto, Portugal.

Erratum in

Erratum regarding previously published articles.
[No authors listed] [No authors listed] Noncoding RNA Res. 2020 Nov 7;5(4):220-221. doi: 10.1016/j.ncrna.2020.11.002. eCollection 2020 Dec. Noncoding RNA Res. 2020. PMID: 33294748 Free PMC article.

No abstract available

1. Johnson F.L. Pathophysiology and etiology of heart failure. Cardiol. Clin. 2014;32:9–19. - PubMed
1. Kehat I., Molkentin J.D. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010;122:2727–2735. - PMC - PubMed
1. Lips D.J., DeWindt L.J., Van Kraaij D.J.W., Doevendans P.A. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur. Heart J. 2003;24:883–896. - PubMed
1. Tuttolomondo A., Simonetta I., Pinto A. MicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure. Expert Opin. Ther. Targets. 2016;20:1287–1300. - PubMed
1. Alberts B. fourth ed. Garland Science; 2002. Molecular Biology of the Cell.